⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2021Movement DisordersOpen Access

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Whitley W. Aamodt Teresa Waligórska Junchao Shen Thomas F. Tropea Andrew Siderowf Daniel Weintraub Murray Grossman David J. Irwin David A. Wolk Sharon X. Xie John Q. Trojanowski Leslie M. Shaw Alice Chen‐Plotkin

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Plasma NfL is a useful prognostic biomarker for PD, predicting clinical conversion to mild cognitive impairment or dementia.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Aamodt et al. (2021) studied this question.

synapsesocial.com/papers/69d9217d7fca1f84ab6843ef https://doi.org/10.1002/mds.28779

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsClinical Trial · 2017 · 314 citations
2Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesCase-Control Study · 2013 · 497 citations
3Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement DisordersCase-Control Study · 2018 · 253 citations
4Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyCohort Study · 2019 · 777 citations
5Blood-based NfLCohort Study · 2017 · 506 citations
6Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson diseaseDiagnostic Study · 2018 · 251 citations
7Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-AnalysisMeta-Analysis · 2019 · 94 citations
8A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease BiobankOriginal Research · 2013 · 234 citations
9Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's DiseaseMovement Disorders · 2026
10Early and Extensive Degeneration of Sensory Neurons in Spinocerebellar Ataxia Type 3Movement Disorders · 2026

More from Movement Disorders

More from University of Pennsylvania

More from Veterans Health Administration

More from Mental Illness Research, Education and Clinical Centers

More from Institute for Neurodegenerative Disorders

More from Philadelphia VA Medical Center